Finotti Michele, D'Amico Francesco, Mulligan David, Testa Giuliano
Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX, USA.
Transplantation and Hepatobiliary Surgery, University of Padova, Padova, Italy.
Hepatobiliary Surg Nutr. 2023 Feb 28;12(1):56-68. doi: 10.21037/hbsn-21-115. Epub 2021 Aug 20.
Minimally invasive surgery (MIS) is the technique of choice in selected patients for the treatment of liver tumors. The robotic approach is considered today the natural evolution of MIS. The application of the robotic technique in liver transplantation (LT) has been recently evaluated, especially in the living donation. The aim of this paper is to review the current role of the MIS and robotic donor hepatectomy in the literature and to evaluate the possible future implication in the transplant field.
We conducted a narrative review using PubMed and Google Scholar for reports published so far, using the following keywords: minimally invasive liver surgery, laparoscopic liver surgery, robotic liver surgery, robotic living donation, laparoscopic donor hepatectomy and robotic donor hepatectomy.
Several advantages have been claimed in favor of robotic surgery: three-dimensional (3-D) imaging with stable and high-definition view; a more rapid learning curve than the laparoscopic one; the lack of hand tremors and the freedom of movements. Compared to open surgery, the benefits showed in the studies evaluating the robotic approach in the living donation are: less postoperative pain, the shorter period before returning to normal activity despite sustaining longer operation time. Furthermore, the 3-D and magnification view makes the technique excellent in distinguishing the right plane of transection, vascular and biliary anatomy, associated with high precision of the movements and a better bleeding control (essential for donor safety) and lower rate of vascular injury.
The current literature does not fully support the superiority of the robotic approach versus laparoscopic or open method in living donor hepatectomy. Robotic donor hepatectomy performed by teams with high expertise and in properly selected living donors is safe and feasible. However, further data are necessary to evaluate properly the role of robotic surgery in the field of living donation.
微创手术(MIS)是治疗肝脏肿瘤的特定患者的首选技术。如今,机器人手术方法被认为是微创手术的自然发展。最近对机器人技术在肝移植(LT)中的应用进行了评估,特别是在活体肝移植方面。本文旨在综述文献中微创手术和机器人供体肝切除术的当前作用,并评估其在移植领域未来可能产生的影响。
我们使用PubMed和谷歌学术对迄今为止发表的报告进行了叙述性综述,使用了以下关键词:微创肝脏手术、腹腔镜肝脏手术、机器人肝脏手术、机器人活体肝移植、腹腔镜供体肝切除术和机器人供体肝切除术。
人们声称机器人手术有几个优点:具有稳定和高清视野的三维(3-D)成像;学习曲线比腹腔镜手术更短;没有手部震颤且动作更自由。与开放手术相比,在评估机器人手术方法用于活体肝移植的研究中显示出的益处有:术后疼痛较轻,尽管手术时间较长,但恢复正常活动前的时间较短。此外,三维和放大视野使该技术在区分正确的横断平面、血管和胆管解剖结构方面表现出色,同时动作精度高、出血控制更好(这对供体安全至关重要)以及血管损伤率较低。
目前的文献并不完全支持机器人手术方法在活体供体肝切除术中优于腹腔镜或开放手术方法。由专业水平高的团队对经过适当选择的活体供体进行机器人供体肝切除术是安全可行的。然而,需要更多数据来正确评估机器人手术在活体肝移植领域的作用。